News
Non-inferiority trial to assess safety and efficacy, including rates of disease rebound and incidence of Long COVID development of ratutrelvir, a ritonavir-free treatment, compared to PAXLOVID® Separa ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback